PMID: 3333881Jan 1, 1987Paper

Aspects of anticoagulant action: a review of the pharmacology, metabolism and toxicology of warfarin and congeners

Reviews on Drug Metabolism and Drug Interactions
F A SutcliffeG G Gibson

Abstract

Warfarin is the most widely used anticoagulant in the treatment of thromboembolism in man. It has also been used extensively as a rodenticidal agent. Insofar as its clinical use is concerned, it is now clear that many of the drug interactions observed in patients are mediated via metabolic or pharmacokinetic factors. An understanding of the disposition of warfarin is therefore essential if one is to predict the likely response in patients undergoing anticoagulant therapy with this compound. Warfarin-resistance has been reported in both man and rodents. Understanding resistance in both man and rodents is important for effective anticoagulant therapy, and in control of resistant strains of rodents. Warfarin resistance in rat strains does not appear to have a metabolic or pharmacokinetic basis; in this species, resistance is thought to be due to differences in permeability to, or affinity for a receptor. Apart from its clinical and rodenticidal uses, warfarin is an excellent substrate for probing the heterogeneity of cytochrome P.450, since its metabolic oxidation is mediated by this mixed function oxidase. This review draws together much of the current published literature on the pharmacology, metabolism and toxicology of warfari...Continue Reading

References

Apr 1, 1978·The Journal of Pharmacy and Pharmacology·L T WongB H Thomas
Aug 23, 1976·Biochemical and Biophysical Research Communications·P V HauschkaP M Gallop
Jan 1, 1977·European Journal of Clinical Pharmacology·W DieterleW Theobald
May 1, 1979·Clinical Pharmacology and Therapeutics·R J Levy, J B Lian
Mar 7, 1979·Biochimica Et Biophysica Acta·P A FriedmanJ K Wallace
Jun 13, 1979·Biochemical and Biophysical Research Communications·P BeauneJ P Leroux
Sep 1, 1979·Proceedings of the Society for Experimental Biology and Medicine·D V Shah, J W Suttie
Sep 1, 1979·British Journal of Clinical Pharmacology·P A RoutledgeM D Rawlins
Dec 15, 1977·Biochemical Pharmacology·E M SellerJ Koch-Weser
Dec 25, 1978·Life Sciences·J BaronF P Guengerich
Mar 17, 1977·The New England Journal of Medicine·J Stenflo
Sep 27, 1977·Biochimica Et Biophysica Acta·P A FriedmanA Fitz-James
Oct 1, 1976·Biochemical Pharmacology·L R PohlJ W Fenton
Oct 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·P V HauschkaP M Gallop
Apr 1, 1976·The Journal of Hygiene·M E Wallace, F J MacSwiney
Feb 5, 1976·The New England Journal of Medicine·J Koch-Weser, E M Sellers
Mar 15, 1975·British Medical Journal·D B Barnett, B W Hancock
Oct 1, 1975·Proceedings of the Society for Experimental Biology and Medicine·D V Shah, J W Suttie
Jan 1, 1971·Acta Medica Scandinavica·J M HansenL K Christensen
Jan 1, 1971·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·K C Leibman
Dec 1, 1968·The Journal of Clinical Investigation·E S Vesell, J G Page
May 1, 1970·Clinical Pharmacology and Therapeutics·W W Coon, P W Willis
Feb 15, 1969·Nature·W H ShillingR C Longland
Aug 1, 1968·Biochemical Pharmacology·M IkedaH Staudinger
Nov 26, 1973·Annals of the New York Academy of Sciences·R A O'Reilly
Nov 1, 1973·Clinical Pharmacology and Therapeutics·A Breckenridge, M L Orme
Aug 1, 1974·Clinical Pharmacology and Therapeutics·R A O'Reilly
Jan 1, 1974·Vitamins and Hormones·R E Olson
Dec 1, 1972·Journal of Medicinal Chemistry·K K ChanW F Trager
Apr 8, 1972·Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology·A Breckenridge, M L Orme
May 1, 1973·Laboratory Animals·J H Greaves, P Ayres
Apr 1, 1973·British Journal of Haematology·M J ShearerP Barkhan
Jun 1, 1974·The Journal of Clinical Investigation·R J LewisW Schary
Aug 16, 1974·Science·D M Jerina, J W Daly
Jul 6, 1971·Annals of the New York Academy of Sciences·R J Lewis, W F Trager
May 1, 1970·The Journal of Clinical Investigation·R J Lewis, W F Trager
Oct 1, 1970·The American Journal of Physiology·M J ThierryJ W Suttie
Jan 1, 1969·Journal of Pharmaceutical Sciences·P A Harris, S Riegelman
Aug 1, 1965·Archives of Environmental Health·B Fristedt, N Sterner
Nov 1, 1963·The American Journal of Physiology·E Lechler, G D Penick
Jan 1, 1981·The Journal of Pharmacy and Pharmacology·B K Park, J B Leck
May 19, 1983·The New England Journal of Medicine·S J Kempin
Jan 1, 1981·Annals of Biomedical Engineering·T J O'Leary, P H Abbrecht
Jan 1, 1981·Annals of Internal Medicine·M LeeR Sharifi
Mar 1, 1980·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·L T Wong, G Solomonraj
Jun 1, 1953·Journal of the American Pharmaceutical Association·E C HAGAN, J L RADOMSKI
Apr 29, 1961·Nature·A DENYES, J D CARTER
Dec 1, 1960·The Journal of Nutrition·V C Metta, B C Johnson
Oct 1, 1963·The Journal of Clinical Investigation·R A O'ReillyL S LEONG
Feb 1, 1964·Proceedings of the Society for Experimental Biology and Medicine·B A WESTFALLS GARB
Oct 15, 1964·The New England Journal of Medicine·R A O'ReillyM L KROPATKIN
Aug 15, 1964·Nature·M LUND
Apr 1, 1965·Biochemical Pharmacology·L M GONYEA, BRIDGESRA
Jun 1, 1935·The Biochemical Journal·H Dam

Citations

May 9, 2001·Current Treatment Options in Cardiovascular Medicine·Marie Gerhard-Herman
Aug 1, 1994·Pharmacology & Therapeutics·A Lozada, C A Dujovne
Jun 27, 1991·The New England Journal of Medicine·J Hirsh
Mar 1, 1992·British Journal of Clinical Pharmacology·P HonkakoskiO Pelkonen
Jun 1, 1987·Clinical and Experimental Pharmacology & Physiology·F C LeeJ S Lee
Jun 1, 1992·Pharmacology & Toxicology·M L AitioH Bartsch
Feb 6, 2010·World Journal of Gastrointestinal Pharmacology and Therapeutics·Rajesh PendlimariAravind Sugumar
Dec 26, 2006·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·E Koch, A Biber
Oct 31, 2012·Pest Management Science·Julie VeinPhilippe Berny
Jan 11, 2005·Hematology/oncology Clinics of North America·Graham F Pineo, Russell D Hull
Feb 8, 2005·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Michael H RobinsonGary R Martin
Apr 25, 1992·Biochemical and Biophysical Research Communications·D ApanovitchF G Walz
Jan 10, 2002·Blood·Deborah J Stearns-KurosawaShinichiro Kurosawa
Jun 8, 2002·Regulatory Toxicology and Pharmacology : RTP·L T HaberM L Dourson

Related Concepts

Drug Resistance
Vitamin K
Gen-Warfarin

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.

Related Papers

Toxicology
N J van Sittert, C P Tuinman
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
W J CantorB H Strauss
The New England Journal of Medicine
J Margolis, L S Margolis
© 2021 Meta ULC. All rights reserved